Neuren Pharmaceuticals | NEU - Ebitda



Neuren Pharmaceuticals reported AUD176.7M in EBITDA for its fiscal semester ending in December of 2024.


Ebitda Change Date
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Avita Medical AUD -9863000 3.95M Dec/2024
Clinuvel Pharmaceuticals AUD 40.01M 21.64M Jun/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Genetic Signatures AUD -7114000 970K Dec/2024
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Organon & Co USD 522M 114M Jun/2025
Paradigm Biopharmaceuticals AUD -5859230 3.79M Dec/2024
PYC Therapeutics AUD -25596250 3.68M Dec/2024
Starpharma Holdings AUD -4853000 1.73M Dec/2024
Tectonic Therapeutic USD -13483000 5.73M Dec/2024
Telix Pharmaceuticals AUD 33.24M 21.45M Jun/2025
Viatris USD 1.08B 218.1M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025